We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Laura Elizabeth Lansdowne

Science Writer

Writes for:

Drug Discovery Cancer Research

Latest Content From Laura Elizabeth Lansdowne

Deciphering RNA to Predict if a Patient Will Respond to a Targeted Drug
Blog

We recently spoke to Alif Saleh, CEO of Scipher Medicine to learn how RNA data from a patient’s blood sample can be used to determine the underlying molecular processes driving a disease, and establish how well a patient will respond to a particular therapy.

VIEW

Exploring the Tumor Microenvironment
Infographic

In this infographic, we look at what the tumor microenvironment is, the cells and factors that comprise it, how single-cell sequencing can be used to investigate it, and the therapeutics that target it.

VIEW

Converting Cancer Cells to Fat Cells to Stop Cancer’s Spread
News

A method for fooling breast cancer cells into fat cells has been discovered by researchers from the University of Basel.

VIEW

The Biochemistry and Pharmacologic Properties of Cannabis-derived Terpenoids
Article

Terpenoids are responsible for the unique aroma of cannabis. These compounds are lipophilic, can permeate lipid membranes, and several are capable of crossing the blood-brain barrier after inhalation. We recently spoke to Ethan Russo, MD, to learn more about the biochemistry and potential pharmacologic properties of cannabis-derived terpenoids.

VIEW

If We Asked Your Parents to Describe Your Job What Would They Say?
List

We asked you the question "How would your parents describe your job?".
Here is a selection of our favorite responses.

VIEW

What’s the Most Annoying Thing Your Lab Mates Have Ever Done?
List

We asked you tell us the most annoying thing that your lab mates have ever done. We were overwhelmed with the responses that we received, so we decided to pick the funniest and share them with you!

VIEW

Top 10 Cancer Research News Stories of 2018
List

2018 has been an exciting year for the cancer research field. This list details the top 10 most-read news stories we published from the field this year.

VIEW

Combating Neurodegenerative & Age-related Diseases
Blog

We recently spoke to Karoly Nikolich, chairman and chief executive officer of Alkahest, a clinical-stage biotechnology company, to learn more about their approach to developing therapeutics for both neurodegenerative and age-related diseases.

VIEW

Cell Signaling in Cancer
Article

This article discusses the relationship between cell signaling and cancer, highlights key signaling pathways involved in cancer, and explores how critical mediators of aberrant signaling can be turned into therapeutic targets for cancer.

VIEW

Top 10 Drug Discovery News Stories of 2018
List

2018 has been an exciting year for the drug discovery field. This list details the top 10 most-read news stories we published from the field this year.

VIEW